stock-detail (MGNX)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/24/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/19/2017 12:18 pm

4/18/2017 06:18 am

4/18/2017 06:18 am

4/18/2017 06:18 am

4/18/2017 06:18 am

Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017

3/31/2017 11:03 am

[GlobeNewswire] - Rockville, MD, March 31, 2017--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...

MacroGenics to Present at the Needham Healthcare Conference

3/29/2017 09:03 pm

[GlobeNewswire] - Rockville, MD, March 29, 2017--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...

MACROGENICS INC Financials

3/7/2017 06:00 pm

MacroGenics Provides Update on Corporate Progress and 2016 Financial Results

2/28/2017 09:00 pm

[GlobeNewswire] - ROCKVILLE, Md., Feb. 28, 2017-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...

MacroGenics to Participate in Two Upcoming Investor Conferences

2/27/2017 10:03 pm

[GlobeNewswire] - Rockville, MD, Feb. 27, 2017---- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...

MacroGenics Announces Date of Fourth Quarter and Full Year 2016 Financial Results Conference Call

2/16/2017 09:03 pm

[GlobeNewswire] - ROCKVILLE, MD, Feb. 16, 2017-- MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of ...